Hoffman Warnick Helps Vanda Protect Drug Treatment Patent
Hoffman Warnick Helps Vanda Protect Drug Treatment Patent We are proud to have assisted our client, Vanda Pharmaceuticals, in an important patent case that allows the company to retain market exclusivity for one of their important drug products until 2027. On January 13, 2020, the US Supreme Court denied Hikma Pharmaceuticals’ petition for a writ…